WuXi AppTec:

Established in December 2000, WuXi AppTec (NYSE: WX) is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with operations in China and the United States. As an innovation-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of services throughout the drug R&D process. Our services are designed to help our worldwide customers shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient solutions.


Compound management, Medicinal Chemistry, Synthetic Chemistry, Analytical Chemistry, Bioanalytical services, ADME profiling/DMPK, Clinical trials, Medical device, Biologics, Formulation, Manufacturing, Regulatory Affairs







© 2015 The World of CROs. All rights reserved.